Publicaciones en las que colabora con CARMEN RODRÍGUEZ-AVIAL LÓPEZ-DORIGA (17)

2023

  1. High rates of colonization by Staphylococcus aureus in medical students before doing their clinical practices

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 4, pp. 251-253

2022

  1. Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli

    Medical Microbiology and Immunology, Vol. 211, Núm. 5-6, pp. 269-272

2020

  1. Synergy of linezolid with several antimicrobial agents against linezolid-methicillin-resistant staphylococcal strains

    Antibiotics, Vol. 9, Núm. 8, pp. 1-13

2017

  1. Plazomicin activity against 346 extended-spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates in relation to aminoglycoside-modifying enzymes

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 2

2015

  1. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains

    International Journal of Antimicrobial Agents

2014

  1. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: High percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates

    International Journal of Antimicrobial Agents, Vol. 43, Núm. 5, pp. 460-464

2013

  1. Aumento significativo de la resistencia a fosfomicina en cepas de escherichia coli productoras de β-lactamasas de espectro extendido (BLEE) aisladas de urocultivos (2005-2009-2011)

    Revista Espanola de Quimioterapia, Vol. 26, Núm. 1, pp. 43-46

2012

  1. Klebsiella pneumoniae: Development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient

    Clinical Microbiology and Infection, Vol. 18, Núm. 1, pp. 61-66

2010

  1. High percentage of resistance to ciprofloxacin and qnrB19 gene identified in urinary isolates of extended-spectrum β-lactamase-producing Escherichia coli in Madrid, Spain

    Diagnostic Microbiology and Infectious Disease, Vol. 67, Núm. 4, pp. 380-383

2007

  1. Fluoroquinolone resistance among invasive viridans group streptococci and Streptococcus bovis isolated in Spain

    International Journal of Antimicrobial Agents

2006

  1. In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates

    International Journal of Antimicrobial Agents, Vol. 27, Núm. 4, pp. 303-306

2005

  1. In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: Antimicrobial susceptibility patterns in different groups of species

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 2, pp. 820-823

  2. Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: Decreased susceptibility to 6 fluoroquinolones

    Diagnostic Microbiology and Infectious Disease

2003

  1. Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid

    International Journal of Antimicrobial Agents, Vol. 21, Núm. 6, pp. 536-541

2001

  1. Actividad in vitro de seis fluoroquinolonas y penicilina frente a 101 estreptococos del grupo viridans caracterizados en su resistencia a la eritromicina

    Revista Espanola de Quimioterapia, Vol. 14, Núm. 4, pp. 364-368

1999

  1. Fenotipos de resistencia a macrolidos, lincosamidas y estreptograminas en streptococcus del grupo viridans aislados de hemocultivos

    Revista Espanola de Quimioterapia, Vol. 12, Núm. 4, pp. 346-351

1998

  1. Resistencia intrínseca de Haemophilus influenzae a los betalactámicos

    Medicina Clinica, Vol. 110, Núm. SUPPL. 1, pp. 52-59